Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry-Reference-Cited by-同舟云学术

Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry

Published:2012-10-28 Issue:5 Volume:27 Page:615-621
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomed. Chromatogr.

Author:

Qiu Feng¹,Bian Weihua²,Li Jun³,Ge Zhicheng³

Affiliation:

1. Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences; Peking Union Medical College; Beijing; 100193; China

2. Department of Cell Biology; Binzhou Medical University; Yantai; 264003; China

3. Beijing Friendship Hospital of Capital Medical University; No. 95 Yong An Road; Beijing; 100050; China

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference29 articles.

1. Sunitinib maleate;Atkins;Nature Reviews. Drug Discovery,2006

2. Quantitation of SU11248, an oral multi-target tyrosine kinase inhibitor, and its metabolite in monkey tissues by liquid chromatograph with tandem mass spectrometry following semi-automated liquid-liquid pretreatment;Barattè;Journal of Chromatography. A,2004

3. Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects;Bello;Anti-Cancer Drugs,2006

4. Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma;Blanchet;Clinica Chimica Acta,2009

5. A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period;Britten;Cancer Chemotherapy and Pharmacology,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Optimized LC-MS/MS Method for Quantification of Sunitinib and N-Desethyl Sunitinib in Human Plasma and Its Application for Therapeutic Drug Monitoring;Therapeutic Drug Monitoring;2023-04-14

2. Magnetic solid phase extraction of Sunitinib malate in urine samples assisted with mixed hemimicelle and spectrophotometric detection;Scientific Reports;2023-02-27

3. Interpretation of MS–MS spectra of small-molecule signal transduction inhibitors using accurate-m/z data and m/z-shifts with stable-isotope-labeled analogues and metabolites;International Journal of Mass Spectrometry;2021-06

4. Analysis of sunitinib malate, a multi-targeted tyrosine kinase inhibitor: A critical review;Microchemical Journal;2021-04

5. HPLC methods for quantifying anticancer drugs in human samples: A systematic review;Analytical Biochemistry;2020-12